Abstract:BACKGROUND:Globally, gastric cancer (GC) is one of the world's most widespread malignancies, with persistent high mortality and morbidity rates. Increasing evidence now suggests that microRNAs (miRNAs) participate in many biological processes, with miR-455-3p having key roles in the progression of diverse cancers. Nevertheless, miR-455-3p function and expression in GC remain unclear.METHODS:We explored miR-455-3p expression in GC using quantitative polymerase chain reaction (qPCR). To further examine the effect of miR-455-3p in GC, after transfecting miR-455-3p mimics or inhibitors into GC cells, 5-ethynyl-2'-deoxyuridine (EdU) incorporation and colony formation assays were performed to examine cell proliferation. Flow cytometry was used to detect apoptosis, and expression levels of Bax, Bcl-2, Snail, N-cadherin, E-cadherin, and Caspase-3 were assessed by western blotting (WB). Using online databases and luciferase assays, we identified armadillo repeat-containing protein 8 (ARMC8) as a promising target of miR-455-3p. A mouse tumor model was established to investigate actions of miR-455-3p in vivo. Expression levels of C-myc, cyclinD1, and β-catenin were examined using WB and immunofluorescence.RESULTS:MiR-455-3p expression was attenuated in GC tissue and cell lines. MiR-455-3p overexpression inhibited GC cell proliferation, epithelial-mesenchymal transition (EMT), as well as facilitated apoptosis, while suppression of miR-455-3p had the opposite effects. From luciferase assays, we confirmed that ARMC8 was a novel and direct downstream target gene of miR-455-3p, and that the tumor suppressive role of miR-455-3p was in part reversed due to ARMC8 overexpression. Moreover, miR-455-3p inhibited GC growth in vivo via ARMC8. We also observed that miR-455-3p repressed canonical Wnt pathway activation by binding to ARMC8.CONCLUSIONS:MiR-455-3p exerted tumor inhibitory effects in GC by targeting ARMC8. Therefore, intervening in the miR-455-3p/ARMC8/Wnt/βcatenin axis could be a promising novel treatment strategy for GC.

Mir‑381 and Mir‑489 Suppress Cell Proliferation and Invasion by Targeting CUL4B Via the Wnt/β‑catenin Pathway in Gastric Cancer.

Cullin 4a (Cul4a), A Direct Target Of Mir-9 And Mir-137, Promotes Gastric Cancer Proliferation And Invasion By Regulating The Hippo Signaling Pathway

CUL4B Promotes Gastric Cancer Invasion and Metastasis-Involvement of Upregulation of HER2

Mir-338-3p Functions As a Tumor Suppressor in Gastric Cancer by Targeting PTP1B

Inhibition of Mir‑194 Suppresses the Wnt/β‑catenin Signalling Pathway in Gastric Cancer.

Cul4a Promotes Cell Invasion in Gastric Cancer by Activating the Nf-Kappa B Signaling Pathway

Mir-301a-5p/Scin Promotes Gastric Cancer Progression Via Regulating Stat3 And Nf-Kappa B Signaling

MiR-1-3p Targets CENPF to Repress Tumor-Relevant Functions of Gastric Cancer Cells

MiR-301a-5p/SCIN promotes gastric cancer progression via regulating STAT3 and NF-κB signaling

CUL4B Contributes to Cancer Stemness by Repressing Tumor Suppressor Mir34a in Colorectal Cancer

Dysregulation of the miR‐194–CUL4B negative feedback loop drives tumorigenesis in non‐small‐cell lung carcinoma

Retracted: MicroRNA‐300 Promotes Apoptosis and Inhibits Proliferation, Migration, Invasion and Epithelial‐mesenchymal Transition Via the Wnt/β‐catenin Signaling Pathway by Targeting CUL4B in Pancreatic Cancer Cells

Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile

Mir-644A Inhibits Cellular Proliferation and Invasion Via Suppression of CtBP1 in Gastric Cancer Cells

MiR-455-3p Inhibits Gastric Cancer Progression by Repressing Wnt/β-catenin Signaling Through Binding to ARMC8.

MiR-140-3p Impedes Gastric Cancer Progression and Metastasis by Regulating BCL2/BECN1-Mediated Autophagy

circ‐CEP85L suppresses the proliferation and invasion of gastric cancer by regulating NFKBIA expression via miR‐942‐5p

MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2

MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU

Mir-1273H-5p Suppresses the Penetration and Pervasion of Gastric Cancer Cells Via Suppressing CXCL12 Expression

Mir-188-5p Emerges As an Oncomirna to Promote Gastric Cancer Cell Proliferation and Migration Via Upregulation of SALL4